Literature DB >> 33317235

The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?

Beom Kyung Kim1,2,3.   

Abstract

Entities:  

Keywords:  Cirrhosis; Etiology; Liver stiffness; Portal hypertension

Year:  2020        PMID: 33317235      PMCID: PMC7820203          DOI: 10.3350/cmh.2020.0311

Source DB:  PubMed          Journal:  Clin Mol Hepatol        ISSN: 2287-2728


× No keyword cloud information.
Portal hypertension (PH) is a major consequence of liver tissue fibrogenesis [1] that results in serious complications such as variceal bleeding, ascites, and hepatic encephalopathy among patients with liver cirrhosis [2]. Hence, PH is responsible for significant morbidity and mortality, particularly among patients with decompensated cirrhosis [3,4]. The hepatic venous pressure gradient (HVPG), the gradient between wedged (i.e., balloon-occluded) and free hepatic venous pressure, is considered the reference standard for assessing the degree of PH. Thus, clinically significant PH, usually defined as an HVPG of ≥10 mmHg, is associated with the formation of esophageal varices and with a poor prognosis [5-8]. However, the routine assessment of HVPG in the clinical setting is limited by its invasiveness and the need for expertise and specialized equipment such as an angio-intervention unit. Thus, alternative approaches with acceptable diagnostic performance are needed for clinicians to noninvasively assess PH in patients with cirrhosis. Recently, accumulating evidence has suggested that liver stiffness (LS) assessed using transient elastography (TE) can adequately reflect the findings of HVPG, indicating that it is a useful modality for evaluating PH and the resultant cirrhotic complications [9-15]. However, TE is not sufficiently accurate to replace HVPG due to its insufficient sensitivity and specificity [16]. Furthermore, TE has limitations for clinical application because of the wide range of cutoff values (range, 13.9–21.5 kPa) and variability in performance among studies (area under the receiver operating characteristic curve, 0.76–0.85) [10,17,18]. Recently, Ryu et al. [19] evaluated the correlation between LS, LS to platelet ratio (LPR), LS–spleen diameter-to-platelet ratio score (LSPS), and HVPG according to the etiology of cirrhosis (alcoholic cirrhosis vs. viral cirrhosis). According to the Baveno VI recommendations, an LS cutoff of 21 kPa can be used to confirm the presence of clinically significant PH [11,20]. However, most evidence to support this recommendation was based on studies that had recruited patients with viral cirrhosis. Ryu et al. [19] reported a higher LS value in patients with alcoholic cirrhosis than in those with viral cirrhosis (43.5. vs. 32.0 kPa, P<0.001), whereas there were no significant differences in the LPR or LSPS between the two groups. Ryu et al. [19] also suggested an LS cutoff value of 32.2 kPa with a positive predictive value (PPV) of 94.5% to predict an HVPG ≥10 mmHg and an LS cutoff value of 36.6 kPa with a PPV of 91.0% to predict an HVPG >12 mmHg. However, there are several considerations when interpreting these results. First, while the hypothesis that the higher the LS value, the worse the prognosis might be generally reasonable, the association between the LS value and fibrotic burden might be non-linear. Furthermore, the correlation between the LS value and the risk of PH-related complications might be even more nonlinear, given that LS is primarily a fibrosis-marker and not a hemodynamic parameter. In a similar context, the measurement of spleen stiffness by ultrasound seemed to at least partially overcome the limitations associated with the LS value in the evaluation of PH [21]. In contrast, Ryu et al. [19] showed that the addition of spleen diameter and/or platelet count did not improve the predictive performance compared to that of the LS value alone. Thus, further studies to evaluate the role of other ancillary methods based on laboratory, ultrasonography, and other markers are required. Second, the prognostic performance of alcoholic cirrhosis-specific LS cutoffs should be validated in further studies in which the cumulative risk of PH-related complications, such as variceal hemorrhage, hepatorenal syndrome, hepatic encephalopathy, and hospital admission for other PH-related complications, should be assessed using longitudinal follow-up. Lastly, Ryu et al. [19] suggested several hypotheses explaining their observation: the difference in the spatial distribution of fibrosis, with perisinusoidal fibrosis being more frequent, and concomitant necro-inflammation with steatosis in alcoholic cirrhosis. However, the exact mechanism underlying the increase in LS, the degree of increment in the LS value, and the way to adjust for such microscopic milieus in alcoholic cirrhosis remain to be determined. In conclusion, a relatively higher LS value should be applied to predict clinically significant PH in patients with alcoholic cirrhosis than in patients with viral cirrhosis. However, since the severity of PH is more dependent on the amount of portal blood inflow and peripheral hemodynamic changes than on the stiffness of the hepatic parenchyma, further studies on ways to assess PH non-invasively are required.
  21 in total

1.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

Review 2.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.

Authors:  Moon Young Kim; Ki Tae Suk; Soon Koo Baik; Hyoun A Kim; Young Ju Kim; Seung Hwan Cha; Hwa Ryun Kwak; Mee Yon Cho; Hong Jun Park; Hyo Keun Jeon; So Yeon Park; Bo Ra Kim; Jin Heon Hong; Ki Won Jo; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Sei Jin Chang; Gwang Ho Baik; Dong Joon Kim
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

4.  Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.

Authors:  M Sánchez-Conde; P Miralles; J María Bellón; D Rincón; M Ramírez; I Gutiérrez; C Ripoll; J C López; J Cosín; G Clemente; O Lo Iacono; R Bañares; J Berenguer
Journal:  J Viral Hepat       Date:  2010-09-07       Impact factor: 3.728

5.  Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.

Authors:  Moon Young Kim; Mee Yon Cho; Soon Koo Baik; Hong Jun Park; Hyo Keun Jeon; Chong Kun Im; Chan Sik Won; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Min Seob Eom; Seung Hwan Cha; Young Ju Kim; Sei Jin Chang; Samuel S Lee
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

6.  Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Authors:  Thomas Reiberger; Arnulf Ferlitsch; Berit Anna Payer; Matthias Pinter; Philipp Schwabl; Judith Stift; Michael Trauner; Markus Peck-Radosavljevic
Journal:  Wien Klin Wochenschr       Date:  2012-06-15       Impact factor: 1.704

7.  Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.

Authors:  Laurent Castéra; Brigitte Le Bail; Françoise Roudot-Thoraval; Pierre-Henri Bernard; Juliette Foucher; Wassil Merrouche; Patrice Couzigou; Victor de Lédinghen
Journal:  J Hepatol       Date:  2008-10-26       Impact factor: 25.083

8.  Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis.

Authors:  Xiaowen Ma; Le Wang; Hao Wu; Yuemin Feng; Xibiao Han; Haoran Bu; Qiang Zhu
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

9.  Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?

Authors:  Beom Kyung Kim
Journal:  Clin Mol Hepatol       Date:  2017-03-24

10.  Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.

Authors:  Dongmei Zhao; Guobing Zhang; Mingquan Wang; Chaoxue Zhang; Jiabin Li
Journal:  Clin Mol Hepatol       Date:  2019-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.